New Owner
Merck & Co., Inc. - Idenix Pharmaceuticals
Merck & Co., Inc. acquires Idenix Pharmaceuticals
Announced: June 09, 2014
Type: Acquisition
Disposition: Separate Entity
Terms: Cash
Status: Complete
Amount: $ 3,850,000,000
Merck & Co., Inc. Other Acquisitions
Add Acquisition| Date | Acquired | Amount |
|---|---|---|
| Oct 10, 2017 |
|
$ 752,000,000 |
| Sep 06, 2017 |
|
Undisclosed amount |
| Jul 11, 2016 |
|
Undisclosed amount |
| Jun 09, 2016 |
|
$ 1,250,000,000 |
| Jan 13, 2016 |
|
Undisclosed amount |
| Jul 28, 2015 |
|
$ 95,000,000 |
